The latest T1D content
Research that matters
Our daily questions
Continue with Google
Continue with Facebook
Ospelt, E. Noor, N, Sanchez, J, Nelson, G, Rioles, N, Malik, F. S., Basina, M, Indyk, J, Vendrame, F, Schmitt, J, Scott, M. L., Ebekozien, O
This study sought to identify barriers and facilitators to successful smart insulin pen (SIP) use and gauge prescribing practices and integration into clinical practice by assessing provider and care team perspectives at participating endocrinology clinics within the T1D Exchange Quality Improvement Collaborative. The identified provider-related, patient-related, and clinic- and operational-level barriers and facilitators varied based on clinic knowledge, capacity, and resources. High-impact barriers included insurance coverage and prescribing processes; high-impact facilitators included improved diabetes clinic visit quality and use of SIPs as an alternative to insulin pump therapy. Findings indicated the need for provider and care team education and training on proper SIP features, use, and prescribing.
Click here to view the article!
If you are a member of the T1DX-QI, you can view the full pdf in the portal.
1 Comment
Facilitators and Barriers to Smart Insulin Pen Use: A Mixed-Method Study of Multidisciplinary Stakeholders From Diabetes Teams in the United States
You must be logged in to post a comment.
This study highlights some important insights into the real-world use of smart insulin pens, especially how clinic operations and provider knowledge can impact adoption. The focus on barriers like insurance and prescribing hurdles really shows how system-level improvements are just as crucial as patient education. For anyone interested in exploring something more fun after a deep dive like this, you might want to view more creative ideas for usernames, especially if you’re active on platforms like Discord. Sometimes, switching gears and finding the right online identity can be just as rewarding as solving real-world challenges.